APSR2026-1055

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-023
P78
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1245384-46904-APSR2026_AP08-023_Poster_JeeYounOh_FINAL_429748.pdf
Format: PDF Only
06. Tuberculosis
10

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Jee Youn Oh * Korea University Guro Hospital, Korea University College of Medicine Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine Seoul Republic of Korea
Bumhee Yang - Ulsan University Hospital, University of Ulsan College of Medicine Division of Respiratory and Critical Care Medicine, Department of Internal Medicine Ulsan Republic of Korea
Ganghee Chae - Ulsan University Hospital, University of Ulsan College of Medicine Division of Respiratory and Critical Care Medicine, Department of Internal Medicine Ulsan Republic of Korea
Jinsoo Min - Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Seoul Republic of Korea
Hyung Woo Kim - Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Incheon Republic of Korea
Hyeon-Kyoung Koo - Inje University Ilsan Paik Hospital, Inje University College of Medicine Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Goyang Republic of Korea
Yun-Jeong Jeong - Dongguk University Ilsan Hospital Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Goyang Republic of Korea
Ju Sang Kim - Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Incheon Republic of Korea
Sung Soon Lee - Inje University Ilsan Paik Hospital, Inje University College of Medicine Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Goyang Republic of Korea
Jae Seuk Park - Dankook University College of Medicine Division of Pulmonary Medicine, Department of Internal Medicine Cheonan Republic of Korea
 
 
 
 
 
Presenting Author Details
Jee Youn
Oh
happymaria0101@hanmail.net
+821037141181
41-50
 
Original Research
Chronic kidney disease abolishes the age-related survival advantage in tuberculosis: identifying potentially preventable deaths in younger patients
Maximum 25 words
Abstract Content
Tuberculosis (TB) mortality is strongly age-dependent, and younger patients are often regarded as low risk. Chronic kidney disease (CKD) may disrupt this age-based risk stratification, but whether younger CKD patients reach an elderly-equivalent mortality stratum remains unclear.
We analysed the Korea Tuberculosis Cohort from 2018 to 2024. CKD was defined as registry-documented chronic renal disease. The primary outcome was all-cause mortality during TB treatment. Patients were classified by age (<65 or ≥65 years) and CKD status. Kaplan-Meier curves were constructed using treatment-to-outcome intervals when available. Among patients aged <65 years, CKD was compared with other major comorbidities using modified Poisson regression. Within CKD patients aged <65 years, deceased and surviving patients were compared, and variables associated with mortality in univariable screening were entered into a multivariable modified Poisson model.
Among 36,269 patients with known treatment outcome, 1,516 had CKD and 3,380 deaths occurred. Patients aged <65 years with CKD had mortality of 14.8%, comparable to patients aged >=65 years without CKD (14.1%) and markedly higher than patients aged <65 years without CKD (3.4%). In Kaplan-Meier analysis, the survival curve of patients aged <65 years with CKD approximated that of patients aged >=65 years without CKD (log-rank p=0.706), whereas it was significantly worse than that of patients aged <65 years without CKD (p<0.001). Among patients aged <65 years, CKD showed an adjusted mortality risk comparable to malignancy and higher than diabetes, chronic lung disease, and chronic heart disease. Within CKD patients aged <65 years, death clustered with absence of cohabiting family, heavy alcohol use, dyspnea, general weakness, CNS disease, and sputum PCR positivity, whereas median eGFR and diabetes prevalence did not differ significantly between deceased and surviving CKD patients.
CKD abolishes the usual survival advantage of younger age in TB. Patients aged <65 years with CKD should be classified as high risk at TB registration and considered for early renal-centered monitoring with assessment of behavioral, functional, and social vulnerability.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
chronic kidney disease, tuberculosis, mortality
maximum 3 keywords and no abbreviations, separated by commas
The authors declare that they have no competing interests. We thank the TB specialist nurses, participating hospitals, and data managers involved in the Korean public-private mix TB control program and KTBC registry.
328